Showing results (271-280 of 284) with videos related to
Sort By:
Pageof 29
Anti-Cancer Drugs|July 11, 1998
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinomaA P Kudelka, A Hasenburg, C F Verschraegen, et al.Anti-Cancer Drugs|August 1, 1997
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinomaA P Kudelka, Z H Siddik, D Tresukosol, et al.Anti-Cancer Drugs|June 23, 1999
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancerC F Verschraegen, E Gupta, E Loyer, et al.Anti-Cancer Drugs|September 1, 1996
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literatureS Piamsomboon, W Termrungruanglert, A P Kudelka, et al.Bone Marrow Transplantation|May 4, 2004
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantationM L Donato, A Aleman, R E Champlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervixC F Verschraegen, T Levy, A P Kudelka, et al.Environmental Health Perspectives|April 1, 1997
During development, 17alpha-estradiol is a potent estrogen and carcinogenR A Hajek, A D Robertson, D A Johnston, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinomaA. P. Kudelka, C. F. Verschraegen, Y. Shen, et al.Bone Marrow Transplantation|June 13, 2000
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancerM L Donato, D Gershenson, C Ippoliti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinomaA P Kudelka, D Tresukosol, C L Edwards, et al.Pageof 29